These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 24120728)

  • 21. Adipocytes as lipid sensors of oleic acid transport through a functional Caco-2/HT29-MTX intestinal barrier.
    Berger E; Géloën A
    Adipocyte; 2019 Dec; 8(1):83-97. PubMed ID: 30905315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HT29-MTX and Caco-2/TC7 monolayers as predictive models for human intestinal absorption: role of the mucus layer.
    Pontier C; Pachot J; Botham R; Lenfant B; Arnaud P
    J Pharm Sci; 2001 Oct; 90(10):1608-19. PubMed ID: 11745719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The in vitro intestinal cell model: different co-cultured cells create different applications.
    Zou X; Liu Y; Cui M; Wan Q; Chu X
    J Drug Target; 2024 Jun; 32(5):529-543. PubMed ID: 38537662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimization of Caco-2 and HT29 co-culture in vitro cell models for permeability studies.
    Pan F; Han L; Zhang Y; Yu Y; Liu J
    Int J Food Sci Nutr; 2015; 66(6):680-5. PubMed ID: 26299896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Facilitated nanoscale delivery of insulin across intestinal membrane models.
    Woitiski CB; Sarmento B; Carvalho RA; Neufeld RJ; Veiga F
    Int J Pharm; 2011 Jun; 412(1-2):123-31. PubMed ID: 21501675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the Caco-2, HT-29 and the mucus-secreting HT29-MTX intestinal cell models to investigate Salmonella adhesion and invasion.
    Gagnon M; Zihler Berner A; Chervet N; Chassard C; Lacroix C
    J Microbiol Methods; 2013 Sep; 94(3):274-9. PubMed ID: 23835135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The gut barrier: new acquisitions and therapeutic approaches.
    Scaldaferri F; Pizzoferrato M; Gerardi V; Lopetuso L; Gasbarrini A
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S12-7. PubMed ID: 22955350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A protocol for differentiation of human intestinal Caco-2 cells in asymmetric serum-containing medium.
    Ferruzza S; Rossi C; Scarino ML; Sambuy Y
    Toxicol In Vitro; 2012 Dec; 26(8):1252-5. PubMed ID: 22265977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SEDDS for intestinal absorption of insulin: Application of Caco-2 and Caco-2/HT29 co-culture monolayers and intra-jejunal instillation in rats.
    Liu J; Werner U; Funke M; Besenius M; Saaby L; Fanø M; Mu H; Müllertz A
    Int J Pharm; 2019 Apr; 560():377-384. PubMed ID: 30790612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics.
    Sambuy Y; De Angelis I; Ranaldi G; Scarino ML; Stammati A; Zucco F
    Cell Biol Toxicol; 2005 Jan; 21(1):1-26. PubMed ID: 15868485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of hydrogel scaffolds to develop an in vitro 3D culture model of human intestinal epithelium.
    Dosh RH; Essa A; Jordan-Mahy N; Sammon C; Le Maitre CL
    Acta Biomater; 2017 Oct; 62():128-143. PubMed ID: 28859901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Caco-2 Model: Modifications and enhancements to improve efficiency and predictive performance.
    Panse N; Gerk PM
    Int J Pharm; 2022 Aug; 624():122004. PubMed ID: 35820514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro evaluation of intestinal fluoride absorption using different cell models.
    Rocha RA; Vélez D; Devesa V
    Toxicol Lett; 2012 May; 210(3):311-7. PubMed ID: 22387159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dextran-protamine coated nanostructured lipid carriers as mucus-penetrating nanoparticles for lipophilic drugs.
    Beloqui A; Solinís MÁ; des Rieux A; Préat V; Rodríguez-Gascón A
    Int J Pharm; 2014 Jul; 468(1-2):105-11. PubMed ID: 24746410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A three-dimensional coculture of enterocytes, monocytes and dendritic cells to model inflamed intestinal mucosa in vitro.
    Leonard F; Collnot EM; Lehr CM
    Mol Pharm; 2010 Dec; 7(6):2103-19. PubMed ID: 20809575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of secretory immunoglobulin A on bacterial translocation in an enterocyte-lymphocyte co-culture model.
    Sawai T; Goldstone N; Drongowski RA; Coran AG; Harmon CM
    Pediatr Surg Int; 2001 May; 17(4):275-9. PubMed ID: 11409161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of HT29-18-C1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption.
    Collett A; Sims E; Walker D; He YL; Ayrton J; Rowland M; Warhurst G
    Pharm Res; 1996 Feb; 13(2):216-21. PubMed ID: 8932439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caco-2 Cell Sheet Partially Laminated with HT29-MTX Cells as a Novel In Vitro Model of Gut Epithelium Drug Permeability.
    Cheng Y; Watanabe C; Ando Y; Kitaoka S; Egawa Y; Takashima T; Matsumoto A; Murakami M
    Pharmaceutics; 2023 Sep; 15(9):. PubMed ID: 37765306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancing the Furosemide Permeability by Papain Minitablets Through a Triple Co-culture In Vitro Intestinal Cell Model.
    Corazza FG; Ernesto JV; Nambu FAN; Calixto LA; Varca GHC; Vieira DP; Leite-Silva VR; Andréo-Filho N; Lopes PS
    AAPS PharmSciTech; 2020 Sep; 21(7):255. PubMed ID: 32888072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a serum-free co-culture of human intestinal epithelium cell-lines (Caco-2/HT29-5M21).
    Nollevaux G; Devillé C; El Moualij B; Zorzi W; Deloyer P; Schneider YJ; Peulen O; Dandrifosse G
    BMC Cell Biol; 2006 May; 7():20. PubMed ID: 16670004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.